June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Letter Contrast Sensitivity Validation
Author Affiliations & Notes
  • Michel Guillon
    Ocular Technology Group International, London, London, United Kingdom
    School of Heath Sciences, Aston University, Birmingham, United Kingdom
  • Pasquale Pepe
    Ocular Technology Group International, London, London, United Kingdom
  • Jessie Hull
    Alcon Inc., Fort Worth, Texas, United States
  • Rajaraman Suryakumar
    Alcon Inc., Fort Worth, Texas, United States
  • Footnotes
    Commercial Relationships   Michel Guillon Alcon Inc, CooperVision, Novartis, Horus Pharma, International Ltd, Code C (Consultant/Contractor), Optometric Technology Group Ltd, Optometric Technology Group (Jersey) Ltd, ThermaMEDx LLC, Code O (Owner); Pasquale Pepe Optometric Technology Group Jersey Ltd, Code C (Consultant/Contractor); Jessie Hull Alcon Inc., Code E (Employment); Rajaraman Suryakumar Alcon Inc., Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 4218 – A0146. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michel Guillon, Pasquale Pepe, Jessie Hull, Rajaraman Suryakumar; Letter Contrast Sensitivity Validation. Invest. Ophthalmol. Vis. Sci. 2022;63(7):4218 – A0146.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Contrast sensitivity measurement with sinusoidal patterns (SinCS) is known to have significant variability and influenced by learning effects. Letter contrast sensitivity (LetCS) using a familiar testing process may be better suited in such a case. The purpose of the study was to validate LetCS produced by an iPad application driving a standard 4K screen compared with SinCS produced by two commercial systems (M&S Technologies (M&S) and Vector Vision (VV) by measuring their repeatability.

Methods : The study was a single arm, prospective, repeated measure study. The study population (n=20), a young presbyopic phakic population (43.6 ±2.8 years; range 40 to 49years) attended an initial enrolment / test familiarisation visit and two test visits. CS was measured under photopic (85cd/m2) and mesopic (3cd/m2) conditions, at five spatial frequencies (SF) 1.5, 3, 6, 12 and 18cpd. Repeatability was established by comparing the mean and 95% CI of the difference between the measurements made at the two test visits and the variance between the measurements.

Results : i. Under photopic conditions test variance was lower at all SF for LetCS (Test-retest difference: mean -0.03 to -0.01logCS; 95%CI 0.05 to 0.07logCS) than for SinCS M&S (Test-retest difference: mean -0.14 to -0.04logCs; 95%CI 0.16 to 0.37logCS) (p ≤ 0.001) and VV (Test-retest difference: mean -0.07 to +0.01logCS; 95%CI 0.12 to 0.18logCS) (p = 0.020 to <0.001). ii. under mesopic conditions test variance was lower at all SF for LetCS (Test-retest difference: mean -0.05 to -0.03logCS; 95%CI 0.11 to 0.16logCS) than SinCS M&S (Test-retest difference: mean -0.11 to -0.04logCs; 95%CI 0.21 to 0.34logCS) (p 0.011 to <0.001) and all SF for VV (Test-retest difference: mean -0.08 to -0.01logCS; 95%CI 0.14 to 0.35logCS) (p = 0.004 to 0.001) other than 6cpd (p=0.973).

Conclusions : Letter contrast sensitivity was shown to be highly repeatable and exhibited significantly lower variance than sinusoidal pattern contrast sensitivity. The implications are that letter contrast sensitivity, needing minimal training, could be well suited for use in clinical studies and its lower variance than sinusoidal contrast sensitivity results in the need for a smaller sample size to achieve the same statistical power than sinusoidal contrast sensitivity.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×